Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Indonesia
Paulina, Ida
Unknown Affiliation
Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluasi Pengobatan Yang Diterima Anak Berkebutuhan Khusus Di Sumatera Selatan, Indonesia Ramatillah, Diana Laila; Dinli, Dwi Yunisa; Ipadeola, Mairo Hamid; Rabima, Rabima; Paulina, Ida; Rofii, Ahmad
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 14 No. 1 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (447.156 KB) | DOI: 10.35617/jfionline.v14i1.11

Abstract

Children with special needs (ABK) are children with different characteristics from children in general who have significant abnormalities (mental-intellectual, physical, social and emotional). This study aims to evaluate the treatment received by children with special needs in South Sumatra. This is a cross-sectional survey conducted among students at SLB South Sumatra using a self-administered questionnaire. The sampling technique was done by convenience sampling. From the results of this study, it is known that there are 53 males and 43 females. Based on the results of the study, it was found that the treatment received by children with special needs, namely DHA (Omega-3) + Vitamin B Complex as many as 20 people (37%) by 20% was influenced by most of those who took medication at the age of 11-15 years. There is a significant relationship between treatment and intelligence level which is indicated by a p-value of 0.02, which shows that 7 people (7%) are good and 89 people (93%). It is also known that there is a significant relationship between comorbidities and treatment, which is indicated by significant p-value (P < 0.001), 35 people (37%), and 61 people (63%). DHA (Omega-3) is the most widely given supplement to students with special needs at the age of 11-15, and only a few students receive depakote (Divalproex Sodium) and multivitamins including Vitamin A, B complex and Vitamin C with an average moderate level of intelligence. This is influenced by comorbidities such as epilepsy.
Evaluasi Hasil Klinis Pada Tim Medis yang Mendapat Vaksinasi Booster di Rumah Sakit Bengkayang Kalimantan Barat Lukas, Stefanus; Ramatillah, Diana Laila; Aldi, Yufri; Wahyuni, Fatma Sri; Paulina, Ida; Gloria, Fransisca; Michael, Michael
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 14 No. 2 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (531.685 KB) | DOI: 10.35617/jfionline.v14i2.70

Abstract

Abstract: In reducing the risk of transmission to health workers, the Government has given the 3rd Booster Covid-19 Vaccination since August 2021. This study uses the Astra Zeneca Vaccine, Moderna Vaccine and Pfizer Vaccine. The purpose of this study was to evaluate the effectiveness of the 3rd Booster vaccine and the clinical outcomes of post-vaccination health workers at West Kalimantan Hospital. Research method Observational Cross-sectional Prospective by conducting questionnaires and interviewing health workers. Samples were taken by convenience sampling and statistical analysis of chis-square. The research instrument used a questionnaire distributed in the hospital. In the study, it was found that as many as 12.60% (14 out of 118 health workers) were infected with Covid-19. The habit that influenced the effectiveness of the 3rd booster vaccination was sunbathing (p <0.05). The low severity of health workers infected with Covid-19 after the 3rd booster vaccine can be seen from the place of treatment, namely 97% independent isolation, 60% without using antivirals and 77% without using antibiotics. The type of vitamin that is most widely used is vitamin C. Hence with this booster vaccination aims to prevent and reduce the severity of patients who contract Covid-19 after vaccination.
Co-Authors Ahmad Rofii Dinli, Dwi Yunisa Fatma Sri Wahyuni Gloria, Fransisca Ipadeola, Mairo Hamid Lukas, Stefanus Michael Michael Rabima, Rabima Ramatillah, Diana Laila Yufri Aldi